Source: FDA FDA Warns Patients and Health Care Professionals Not to Use Compounded Drugs from Fullerton Wellness November 1, 2024 -- FDA is warning patients and health care professionals not to use drugs compounded and distributed by Fullerton Wellness LLC, Ontario, Calif., and distributed to patients by medical offices and clinics Fullerton Wellness is a facility that compounds drugs intended to be sterile, including semaglutide and tirzepatide injections
However, cortical bone thickness was decreased in the semaglutide group ( P = 0.032), while no significant changes in bone microarchitecture or biomechanical strength were noted
For Wegovy Users Wegovy is specifically approved for weight management

Others LIPC IVD LIPC CPS_000161 Lipase colorimetric assay 08 057 982 190 8 057 982 190 08057982190 8057982190 08057982190 LIPC, 200T, cobas c pack green LIPC 07613336121399 Reagents, kits 200 tests cobas c 303/503/703 true 07 041 918 190 7 041 918 190 07041918190 7041918190 07041918190 LIPC, 580T, cobas c 701/702 LIPC 04015630934812 Reagents, kits 580 tests cobas c 701/702 true 05 401 704 190 5 401 704 190 05401704190 5401704190 05401704190 Lipase color 100T c111 LIPC 04015630926985 Reagents, kits 2 50 tests cobas c 111 true 03 029 590 322 3 029 590 322 03029590322 3029590322 03029590322 LIPC, 200Tests, cobas c, Integra LIPC 04015630917570 Reagents, kits 0759007 200 tests COBAS INTEGRA 400 Plus, cobas c 311/501/502 true 08057982500 LIPC Lipase colorimetric assay en 6 FF0000000700010E FF000000045AB60E 08057982190 9493 cobas c 303 8481 cobas c 503 10299 cobas c 703 Product information shown on this page contains elements of the officially released Method Sheet

Testing and supplementing as needed supports bone health and immune function